• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Market Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec11
02:26
Nov26
Kangning Junrui Pharmaceutical-B Resolves to Repurchase Up to HKD 30 Million Ordinary Shares
06:15
Nov17
Knightsbridge Biopharma B Repurchased 350,000 Shares for HKD 3.4198 million
12:48
Nov11
XY Securities Gives 'Outperform' Rating to Conjecta-B
06:22
Nov10
CStone Pharmaceuticals-B Plans Open Market Share Repurchase
00:18
Nov7
Kangning Jierui Pharmaceutical-B Decides to Repurchase Up to 30 Million HKD Ordinary Shares
14:29

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 174.82 M, Net Income 11.81 M, EPS 0.0109

Mar25
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 248.16 M, Net Income 112.36 M, EPS 0.1139

Aug15
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 93.25 M, Net Income -24.12 M, EPS -0.0268

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
08413
0.204
+77.39%
+0.089
01239
0.490
+55.56%
+0.175
01790
0.570
+52.00%
+0.195
08186
0.710
+49.47%
+0.235
08311
0.075
+31.58%
+0.018
00924
0.140
+29.63%
+0.032
08360
0.330
+29.41%
+0.075
00209
0.181
+22.30%
+0.033
02971
0.012
+20.00%
+0.002
08357
0.096
+18.52%
+0.015
View More